Spark Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Spark Investment Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,100	Closed	-$207K	–	765
2018 Q1	$207K	Sell	12,100 -21,300	-64%	-$415K	0.01%	505
2017 Q4	$732K	Buy	+33,400	New	+$1.07M	0.04%	404
2016 Q4	–	Sell	-73,400	Closed	-$3.85M	–	931
2016 Q3	$3.85M	Sell	73,400 -74,700	-50%	-$3.57M	0.31%	91
2016 Q2	$6.12M	Buy	148,100 +130,700	+751%	+$5.69M	0.57%	22
2016 Q1	$706K	Buy	+17,400	New	+$598K	0.07%	371
2015 Q4	–	Sell	-119,000	Closed	-$1.83M	–	894
2015 Q3	$1.83M	Sell	119,000 -16,000	-12%	-$344K	0.24%	129
2015 Q2	$3.35M	Buy	135,000 +8,888	+7%	+$198K	0.47%	41
2015 Q1	$2.88M	Buy	+126,112	New	+$3.18M	0.4%	58

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Spark Investment Management's FPRX Position: Q2 2018 in Review

Spark Investment Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2018, closing a stake of 12,100 shares — an estimated $207K sold.

Spark Investment Management first reported a position in FPRX in Q1 2015 and held it in 8 quarters. The position peaked at $6.12M in Q2 2016. 123 funds tracked by Wall St. Rank hold FPRX as of Q2 2018.

Spark Investment Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Spark Investment Management sold 12,100 Five Prime Therapeutics, Inc. shares in Q2 2018, an estimated $207K.
Spark Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 8 quarters.
Spark Investment Management's Five Prime Therapeutics, Inc. position peaked at $6.12M in Q2 2016.
123 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2018.

Based on Spark Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.